IP Library Assignment 053538/0666
Patent Assignment
Reel/Frame 053538/0666

Security Agreement

Recorded: 2020-08-19 Pages: 11
Assignors
PROGENICS PHARMACEUTICALS, INC.
Executed: 2020-08-18
PSMA DEVELOPMENT COMPANY LLC
Executed: 2020-08-18
Assignee
WELLS FARGO BANK, N.A.
1525 WEST W.T. HARRIS BLVD., CHARLOTTE, NORTH CAROLINA, 28262
Covered Properties (48)
Technetium-Dipyridine Complexes, and Methods of Use Thereof
Patent: 7,381,399 →
Application: 10/386,403 →
Publication: US 2003/0235843
Psma Antibodies and Protein Multimers
Patent: 7,850,971 →
Application: 10/395,894 →
Publication: US 2004/0033229
Technetium-And Rhenium-Bis (Heteroaryl) Complexes, and Methods of Use Thereof
Patent: 8,685,369 →
Application: 10/589,405 →
Publication: US 2008/0025915
PSMA antibody-drug conjugates
Application: 11/471,457 →
Publication: US 2007/0160617
Compositions of Psma Antibodies
Patent: 8,114,965 →
Application: 11/983,372 →
Publication: US 2008/0286284
Technetium-Dipyridine Complexes, and Methods of Use Thereof
Patent: 7,875,258 →
Application: 12/124,736 →
Publication: US 2009/0023787
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,562,945 →
Application: 12/631,312 →
Publication: US 2010/0183509
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof for Inhibiting Psma
Patent: 8,211,401 →
Application: 12/631,337 →
Publication: US 2010/0178246
Process for Production of Heterodimers of Glutamic Acid
Patent: 8,465,725 →
Application: 12/815,637 →
Publication: US 2011/0008253
Psma Antibodies and Uses Thereof
Patent: 8,470,330 →
Application: 12/845,686 →
Publication: US 2011/0165081
Methods for Killing Psma-Expressing, Taxane-Resistant Cancer Cells
Patent: 9,242,012 →
Application: 13/030,105 →
Publication: US 2011/0250216
Heterodimers of Glutamic Acid
Patent: 9,309,193 →
Application: 13/271,549 →
Publication: US 2012/0269726
Heterodimers of Glutamic Acid
Patent: 8,487,129 →
Application: 13/294,677 →
Publication: US 2012/0208988
Radiolabeled Prostate Specific Membrane Antigen Inhibitors
Patent: 8,926,944 →
Application: 13/566,849 →
Publication: US 2013/0034494
Psma Antibodies and Uses Thereof
Patent: 9,695,248 →
Application: 13/608,337 →
Publication: US 2014/0286859
Antibodies for the Treatment of Clostridium Difficile-Associated Infection and Disease
Patent: 8,986,697 →
Application: 13/641,315 →
Publication: US 2013/0202618
Process for Production of Heterodimers of Glutamic Acid
Patent: 9,149,547 →
Application: 13/890,912 →
Publication: US 2014/0030188
Psma-Targeted Dendrimers
Patent: 9,687,572 →
Application: 13/991,812 →
Publication: US 2013/0336888
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,840,865 →
Application: 14/041,643 →
Publication: US 2014/0179902
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Patent: 9,447,121 →
Application: 14/152,864 →
Publication: US 2014/0255306
Combination Therapies with Psma Ligand Conjugates
Application: 14/277,367 →
Publication: US 2015/0110814
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 8,962,799 →
Application: 14/446,220 →
Publication: US 2014/0341805
Radiolabeled Prostate Specific Membrane Antigen Inhibitors
Patent: 9,388,144 →
Application: 14/553,157 →
Publication: US 2015/0078998
Technetium- and Rhenium-Bis(Heteroaryl) Complexes and Methods of Use Thereof
Patent: 9,433,594 →
Application: 14/610,417 →
Publication: US 2016/0222036
Metal Complexes of Poly(Carboxyl)Amine-Containing Ligands Having an Affinity for Carbonic Anhydrase Ix
Patent: 9,422,251 →
Application: 14/820,953 →
Publication: US 2016/0009664
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Patent: 9,956,305 →
Application: 14/846,252 →
Publication: US 2016/0067361
Preparations of Meta-Iodobenzylguanidine and Precursors Thereof
Application: 14/921,898 →
Publication: US 2016/0115267
Heterodimers of Glutamic Acid
Application: 15/068,841 →
Publication: US 2016/0279235
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 15/233,096 →
Publication: US 2016/0346410
Heterodimers of Glutamic Acid
Patent: 9,878,980 →
Application: 15/337,867 →
Publication: US 2017/0044098
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 15/492,933 →
Publication: US 2017/0296683
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 15/794,220 →
Publication: US 2018/0144828
Heterodimers of Glutamic Acid
Application: 15/794,539 →
Publication: US 2018/0111895
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Application: 15/934,304 →
Publication: US 2018/0207299
Systems and Methods for Rapid Neural Network-Based Image Segmentation and Radiopharmaceutical Uptake Determination
Application: 16/003,006 →
Publication: US 2019/0209116
Heterodimers of Glutamic Acid
Application: 16/156,289 →
Publication: US 2019/0276393
Triazine Based Radiopharmaceuticals and Radioimaging Agents
Application: 16/231,153 →
Publication: US 2019/0134237
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/418,527 →
Publication: US 2020/0027559
Preparations of Meta-Iodobenzylguanidine and Precursors Thereof
Application: 16/437,061 →
Publication: US 2019/0367653
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/718,839 →
Publication: US 2020/0126666
Systems and Methods for Artificial Intelligence-Based Image Analysis for Cancer Assessment
Application: 16/734,609 →
Publication: US 2021/0093249
Systems and Methods for Automated and Interactive Analysis of Bone Scan Images for Detection of Metastases
Application: 16/856,120 →
Publication: US 2020/0337658
Organ Protection in Psma-Targeted Radionuclide Therapy of Prostate Cancer
Application: 16/860,925 →
Publication: US 2020/0254120
Heterodimers of Glutamic Acid
Application: 16/870,288 →
Publication: US 2021/0070695
Psma Antibody-Drug Conjugates
Application: 16/921,811 →
Publication: US 2021/0023094
Network for Medical Image Analysis, Decision Support System, and Related Graphical User Interface (Gui) Applications
Application: 16/938,488 →
Publication: US 2020/0357521
Systems and Methods for Rapid Neural Network-Based Image Segmentation and Radiopharmaceutical Uptake Determination
Application: 16/959,887 →
Publication: US 2020/0342600
Systems and Methods for Secure Cloud-Based Medical Image Upload and Processing
Application: 62/907,168 →
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 16, 2012
From: BABICH, JOHN W.; ZIMMERMAN, CRAIG; JOYAL, JOHN L.; LU, GENLIANG
To: MOLECULAR INSIGHT PHARMACEUTICALS
Reel/Frame 029139/0858 →
Release of Patent Security Interest Jan 18, 2013
From: NEXBANK, SSB (AS COLLATERAL AGENT)
To: MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 029660/0618 →
Assignment of Assignor's Interest Oct 10, 2013
From: BABICH, JOHN W.; JOYAL, JOHN L.; ZIMMERMAN, CRAIG
To: MOLECULAR INSIGHT PHARMACEUTICALS
Reel/Frame 031385/0220 →
Assignment of Assignor's Interest Oct 22, 2015
From: MADDON, PAUL J.; DONOVAN, GERALD P.; OLSON, WILLIAM C.; SCHUELKE, NORBERT
To: PSMA DEVELOPMENT COMPANY, LLC
Reel/Frame 036922/0687 →
Release of Security Interest Dec 2, 2022
From: WELLS FARGO BANK, N.A.
To: PROGENICS PHARMACEUTICALS, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC
Reel/Frame 062047/0915 →
Security Interest Dec 2, 2022
From: LANTHEUS MEDICAL IMAGING, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC; PROGENICS PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 062047/0960 →